✦ LIBER ✦

Activating Mutations in the Tyrosine Kinase Domain of the Epidermal Growth Factor Receptor Are Associated with Improved Survival in Gefitinib-Treated Chemorefractory Lung Adenocarcinomas

✍ Scribed by Taron, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mutations in the Tyrosine Kinase Domain

✍ Yang, S. H. 📂 Article 📅 2005 🏛 American Association for Cancer Research 🌐 English ⚖ 134 KB

O-195 Activating mutations (muts) in the

✍ Taron, M.; Santarpia, C.; Ichinose, Y.; Mok, T.; Massuti, B.; Queralt, C.; Sanch 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Mutations of the epidermal growth factor

✍ Murray, S.; Timotheadou, E.; Linardou, H.; Vrettou, A.V.; Kostopoulos, I.; Skric 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 413 KB

Small-Cell Carcinoma With an Epidermal G

✍ Naheed Alam; Karen S. Gustafson; Marc Ladanyi; Maureen F. Zakowski; Atul Kapoor; 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 473 KB

The usefulness of mutation-specific anti

✍ Kozu, Yoshiki; Tsuta, Koji; Kohno, Takashi; Sekine, Ikuo; Yoshida, Akihiko; Wata 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 753 KB

PD-150 Gefitinib (Iressa)-sensitive muta

✍ Mu, X.; Li, L.; Zhang, X.; Wang, M.; Feng, R.; Cui, Q.; Zhou, H.; Guo, B. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 128 KB